昆明積大制藥(yao)股份有限公司成立于(yu)1993年8月8日。
積大(da)(da)制(zhi)藥(yao)的(de)現代化(hua)(hua)生(sheng)(sheng)產(chan)基地(di)位(wei)于云南省發展高(gao)新技(ji)術產(chan)業的(de)基地(di)和外向型經濟的(de)重要窗口——昆明(ming)國(guo)家高(gao)新技(ji)術產(chan)業開發區,占地(di)面積70畝,建筑面積5萬(wan)平方米。目前,積大(da)(da)制(zhi)藥(yao)旗下子(zi)公司(si)包括:專(zhuan)注于銷售的(de)昆明(ming)積大(da)(da)藥(yao)品(pin)銷售有限公司(si);著眼于國(guo)際化(hua)(hua)醫藥(yao)原(yuan)料的(de)無錫積大(da)(da)制(zhi)藥(yao)有限公司(si);從事醫藥(yao)原(yuan)料及藥(yao)品(pin)進出口業務的(de)積大(da)(da)醫藥(yao)(香港)貿易(yi)有限公司(si),以及蘊含高(gao)新科(ke)技(ji)項目的(de)云南積華生(sheng)(sheng)物科(ke)技(ji)有限公司(si),構(gou)建了集制(zhi)劑生(sheng)(sheng)產(chan)、原(yuan)料生(sheng)(sheng)產(chan)、科(ke)研、銷售為一體(ti)的(de)集團化(hua)(hua)模式。
良好而彈性的(de)(de)生產能(neng)力是積大(da)制藥(yao)(yao)賴以實現企業戰略的(de)(de)核心。制劑(ji)(ji)(ji)生產基地(di)現有十三個車(che)(che)間、十六條生產線,全(quan)部通過(guo)(guo)國(guo)家GMP認證(zheng),部分(fen)車(che)(che)間通過(guo)(guo)了國(guo)際市(shi)場的(de)(de)藥(yao)(yao)品(pin)認證(zheng)資(zi)質(zhi)。粉針(zhen)、水(shui)針(zhen)、片劑(ji)(ji)(ji)、膠囊(nang)劑(ji)(ji)(ji)、顆粒劑(ji)(ji)(ji)、混懸劑(ji)(ji)(ji)、預灌注等多個系(xi)列40多個品(pin)種在這具有強(qiang)大(da)綜合優(you)勢的(de)(de)優(you)良制造平臺精心打造,豐(feng)富(fu)的(de)(de)產品(pin)線,增強(qiang)了企業抗(kang)風險能(neng)力。
每條生(sheng)產(chan)(chan)線均具(ju)備(bei)高兼容性(xing)(xing)和(he)互換性(xing)(xing)的(de)(de)精良配置,在(zai)PMC部對供(gong)、產(chan)(chan)、銷的(de)(de)動態(tai)管理下(xia),可(ke)根據市場反饋,實(shi)現迅速(su)換線、換品種生(sheng)產(chan)(chan),提高了企業(ye)的(de)(de)應變能力(li)。
公(gong)(gong)司(si)(si)(si)控(kong)(kong)(kong)(kong)股股東為(wei)(wei)(wei)積華藥(yao)業(ye)有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si)(49%),積華藥(yao)業(ye)有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si)為(wei)(wei)(wei)在香(xiang)港注(zhu)冊成(cheng)立的(de)有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si),主要(yao)從(cong)事(shi)投資(zi)(zi)控(kong)(kong)(kong)(kong)股業(ye)務(wu)。其(qi)他主要(yao)股東為(wei)(wei)(wei):云南(nan)醫藥(yao)工業(ye)股份有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si)(21%),云南(nan)醫藥(yao)工業(ye)股份有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si)為(wei)(wei)(wei)云南(nan)省國(guo)(guo)資(zi)(zi)委轄下的(de)醫藥(yao)有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si)。光(guang)控(kong)(kong)(kong)(kong)遠(yuan)創(chuang)醫藥(yao)投資(zi)(zi)有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si)(11.16%),其(qi)是中(zhong)國(guo)(guo)光(guang)大控(kong)(kong)(kong)(kong)股有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si)下屬的(de)境外投資(zi)(zi)控(kong)(kong)(kong)(kong)股公(gong)(gong)司(si)(si)(si),從(cong)事(shi)投資(zi)(zi)業(ye)務(wu)。成(cheng)都光(guang)控(kong)(kong)(kong)(kong)世紀醫療健(jian)康創(chuang)業(ye)投資(zi)(zi)有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si)(5.58%),其(qi)是中(zhong)國(guo)(guo)光(guang)大控(kong)(kong)(kong)(kong)股有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(si)(si)下屬的(de)境內投資(zi)(zi)控(kong)(kong)(kong)(kong)股公(gong)(gong)司(si)(si)(si),主要(yao)從(cong)事(shi)創(chuang)業(ye)投資(zi)(zi)業(ye)務(wu)。